Listen: Pharma blockbusters, pandemic policy, & legal chicanery
Is the next Lipitor on the way? When is a pandemic over-over? And what’s a Texas two-step? We cover all that and more this week on “The Readout LOUD,” STAT’s …
Read MoreTag: finance
Get care now, pay later?: Health care sees a surge in financing platforms for patients
As inflation-weary shoppers try to make ends meet, many are turning to a modern twist on the layaway plan: buy now, pay later. But while platforms like Afterpay and Affirm …
Read More
Opinion: Rushing into the World Bank’s Pandemic Fund is a bad idea
The World Bank has rolled out a new Financial Intermediary Fund for Pandemic Prevention, Preparedness, and Response (FIF) in an improbable and harmful timetable. Backing of the fund by the …
Read More
Opinion: The conundrum of biopharma investing: low rewards and high risks — but a big social benefit
Over the last decade, investors in biotech and pharmaceutical companies have been taking risks that aren’t commensurate with the rewards. That’s what our new analysis of health care investing shows. …
Read More
Amazon launches new prescribing venture, Google tests search in health care, & Maven’s $90M round
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday …
Read More
Opinion: Allocate opioid settlement dollars to real addiction-ending solutions
The crisis of opioid overdose deaths that sparked the multitude of lawsuits leading to a historic settlement continues to rage, with overdose deaths at an all-time high despite heightened national …
Read More
Collateral damage of the Fed’s interest rate hikes: People who put medical bills on credit cards
Tiffany Yarina didn’t max out her credit card from a home renovation or luxury purchase. It was from cancer. In 2005, Yarina started losing a lot of weight and watched …
Read More
Amazon to acquire One Medical for $3.9 billion in a bold bet on primary care
Retail giant Amazon announced plans Thursday to acquire primary care company One Medical in a cash deal valued at $3.9 billion. The goal of the $18 per share deal is …
Read More
Biotech employees cash in health care’s largest salaries, while people working at providers sit near the bottom
It pays to be in the lab. It pays way less to be at the patient’s bedside. People who work at biotechs, life sciences firms, and pharmaceutical companies pull in …
Read More